Compare ELTX & EDRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ELTX | EDRY |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | United States | Greece |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 63.3M | 72.8M |
| IPO Year | 2014 | 2018 |
| Metric | ELTX | EDRY |
|---|---|---|
| Price | $1.90 | $43.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 3 |
| Target Price | $13.67 | ★ $45.33 |
| AVG Volume (30 Days) | ★ 258.8K | 115.6K |
| Earning Date | 11-12-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 39.29 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,301,000.00 | N/A |
| Revenue This Year | N/A | $40.95 |
| Revenue Next Year | N/A | $8.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.44 | $12.08 |
| 52 Week High | $16.00 | $73.07 |
| Indicator | ELTX | EDRY |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 39.69 |
| Support Level | $1.74 | $18.48 |
| Resistance Level | $1.97 | $53.93 |
| Average True Range (ATR) | 0.15 | 5.01 |
| MACD | 0.04 | -1.20 |
| Stochastic Oscillator | 79.63 | 10.45 |
Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.
EuroDry Ltd is a holding company. It is a provider of ocean-going transportation. The company owns and operates dry bulk carriers that transport bulk such as iron ore, coal, and grains, and minor bulks such as bauxite, phosphate, and fertilizers. It operates under one operating and one reportable segment, that of operating dry bulk vessels.